Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

Clinical trial NCT06094920 · COMPLETED

Trial details

NCT number: NCT06094920
Sponsor: University Medical Center Groningen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2 With Proteinuria Diabetes Mellitus, Type 2 Diabetes Mellitus Diabetes Diabetes Complications Albuminuria Chronic Kidney Diseases Chronic Kidney Disease Due to Type 2 Diabetes Mellitus Chronic Kidney Disease stage3 Chronic Kidney Disease stage4 CKD CKD Stage 3

Start date: 2024-07-29
Primary completion: 2025-09-24
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.